Achaogen, Inc.: Clinical Trials

2 trials sponsored by Achaogen, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Achaogen, Inc.: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)
plazomicin, meropenem, levofloxacin (oral) - Complicated Urinary Tract Infection, Acute Pyelonephritis
Phase 3CompletedAchaogen, Inc.6092016-01-112018-08-23
A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)
plazomicin, colistin, meropenem - Bloodstream Infections (BSI) Due to CRE, Hospital-Acquired Bacterial Pneumonia (HABP) Due to CRE
Phase 3CompletedAchaogen, Inc.692014-09-162018-10-16

Conditions studied

Bacterial Infections (2)  ·  Pneumonia (1)  ·  Sepsis (1)

Interventions

Meropenem (2)  ·  plazomicin (2)  ·  Colistin (1)  ·  Levofloxacin (1)  ·  Tigecycline (1)  ·  colistinmethanesulfonic acid (1)

Top investigators

Lynn E Connolly, MD, PhD (2)

Results publications

PMID 30786187, PMID 31254273

NIH funding

2015 (1)